We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Autoverification of Clinical Laboratory Test Results

By HospiMedica staff writers
Posted on 01 Dec 2006
Automated verification, or autoverification, has emerged as a tool for laboratories whose goal is to streamline their laboratory processes while maintaining the highest quality standards. More...


The Clinical and Laboratory Standards Institute's (CLSI, Wayne, PA, USA) recently published "Autoverification of Clinical Laboratory Test Results; Approved Guideline (AUTO10-A)” provides a general framework that will allow each laboratory to easily design, implement, validate, and customize rules for autoverification based on the needs of its own patient population. Supporting sections are provided that deal with the different aspects of regulatory compliance and validation of algorithms that are essential to establishing and maintaining a modern autoverification system.

According to Dr. William Neeley, Detroit Medical Center, University Laboratories (Detroit, MI, USA), autoverification has many benefits for laboratories. "The AUTO10-A document gives the user the tools to develop algorithms or rules based on medical experience, which can be applied to each and every result. It is as if a highly competent director is personally reviewing every result that is coming out of the laboratory--but it is all done automatically.” He added, "With modern autoverification, rules are written into the software so the technologist does not have to memorize every idiosyncrasy. It enables one to practice medicine more easily and much more consistently.”

AUTO10-A is one of a series of eleven different CLSI-approved documents that address individual portions of an automated laboratory system. It is intended for those involved in point-of-care testing; hospital, reference, independent, and physician office laboratories; formation system vendors; data management vendors; and instrument manufacturers.

CLSI is a global, nonprofit, membership-based organization dedicated to developing standards and guidelines for the healthcare and medical testing community. CSLI facilitates the creation of standards and guidelines that are reliable, practical, and achievable for an effective quality system.



Related Links:
Clinical and Laboratory Standards Institute
Detroit Medical Center, University Laboratories

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Enteral Feeding Pump
SENTINELplus
PACS Workstation
PaxeraView PRO
Infant Resuscitator
Easypuff
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.